HomeBiotechnology

Biotechnology

Sesen (SESN) Halts Bladder Cancer Drug Development, Stock Down

Sesen (SESN) Halts Bladder Cancer Drug Development, Stock Down

July 19, 2022

Incyte (INCY) Gets FDA Nod for Label Expansion of Opzelura

Incyte (INCY) Gets FDA Nod for Label Expansion of Opzelura

July 19, 2022

Acadia (ACAD) Files an NDA for Its Rett Syndrome Candidate

Acadia (ACAD) Files an NDA for Its Rett Syndrome Candidate

July 19, 2022

Gb Sciences Ahead In Digital Transformation in Biopharma Industry Through Its Novel AI-Accelerated Drug Discovery Platform

Gb Sciences Ahead In Digital Transformation in Biopharma Industry Through Its Novel AI-Accelerated Drug Discovery Platform

July 19, 2022

Ultragenyx (RARE) Provides Update From Angelman Syndrome Study

Ultragenyx (RARE) Provides Update From Angelman Syndrome Study

July 19, 2022

Novartis (NVS) Q2 Earnings Beat, Revenues Miss Estimates

Novartis (NVS) Q2 Earnings Beat, Revenues Miss Estimates

July 19, 2022

Apellis Announces FDA Acceptance and Priority Review of the New Drug Application for Pegcetacoplan for the Treatment of Geographic Atrophy (GA)

Apellis Announces FDA Acceptance and Priority Review of the New Drug Application for Pegcetacoplan for the Treatment of Geographic Atrophy (GA)

July 19, 2022

Moderna’s (MRNA) COVID Jab Gets Nod For Kids in Canada

Moderna’s (MRNA) COVID Jab Gets Nod For Kids in Canada

July 18, 2022

AbbVie (ABBV) Seeks EU Nod for Atogepant to Prevent Migraine

AbbVie (ABBV) Seeks EU Nod for Atogepant to Prevent Migraine

July 18, 2022

Will Biogen (BIIB) Succeed in Beating Q2 Earnings Estimates?

Will Biogen (BIIB) Succeed in Beating Q2 Earnings Estimates?

July 18, 2022

« 1 … 17 18 19 20 21 … 543 »